ISO/TC 194
| Registration number (WIID) | Project No. | Title | Status |
|---|---|---|---|
| 90930 | ISO/CD TS 25364-1 | Analytical chemistry matters associated with 10993-18 — Part 1: Identification of organic medical device extractables and leachables in Non-Target Analysis (NTA) | Izstrādē |
| 90931 | ISO/CD TS 25364-2 | Analytical chemistry matters associated with ISO 10993-18 — Part 2: Quantification of medical device extractables and leachables using Non-Targeted Analysis (NTA) | Izstrādē |
| 90932 | ISO/CD TS 25364-3 | Analytical chemistry matters associated with ISO 10993-18 — Part 3: Instrumental and human requirements for evaluating organic medical device extractables and leachables via Non-Targeted Analysis (NTA) | Izstrādē |
| 86799 | ISO/DIS 10993-11 | Biological evaluation of medical devices — Part 11: Tests for systemic toxicity | Aptauja |
| 31481 | ISO/DIS 10993-18 | Biological evaluation of medical devices — Part 18: Chemical characterization of materials | Izstrādē |
| 88199 | ISO/DIS 10993-3 | Biological evaluation of medical devices — Part 3: Evaluation of genotoxicity, carcinogenicity, reproductive toxicity, and developmental toxicity | Aptauja |
| 35976 | ISO/DIS 10993-6 | Biological evaluation of medical devices — Part 6: Tests for local effects after implantation | Izstrādē |
| 84824 | ISO/DIS 10993-7 | Biological evaluation of medical devices — Part 7: Ethylene oxide sterilization residuals | Izstrādē |
| 64238 | ISO/DTR 17137-2 | Cardiovascular implants and extracorporeal systems — Cardiovascular absorbable implants — Part 2: Guidance on biological evaluation of absorbable implants | Izstrādē |
| 84512 | ISO/FDIS 10993-1 | Biological evaluation of medical devices — Part 1: Requirements and general principles for the evaluation of biological safety within a risk management process | Izstrādē |
Displaying 91-100 of 146 results.